AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Preti, RA Lazarus, HM Winter, J Stadtmauer, EA Nadasi, S McMannis, J Karandish, S Jennis, A Goldberg, SL Pecora, AL
Citation: Ra. Preti et al., Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer, CYTOTHERAPY, 3(2), 2001, pp. 85-95

Authors: Pecora, AL
Citation: Al. Pecora, Progress in clinical application of use of progenitor cells expanded with hematopoietic growth factors, CURR OPIN H, 8(3), 2001, pp. 142-148

Authors: Menillo, SA Goldberg, SL McKiernan, P Pecora, AL
Citation: Sa. Menillo et al., Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation, BONE MAR TR, 28(8), 2001, pp. 807-808

Authors: Pecora, AL Stiff, P LeMaistre, CF Bayer, R Bachier, C Goldberg, SL Parthasarathy, M Jennis, AA Smith, AK Douville, J Chen, B Armstrong, RD Mandalam, RK Preti, R
Citation: Al. Pecora et al., A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation, BONE MAR TR, 28(3), 2001, pp. 295-303

Authors: Pecora, AL Lazarus, HM Stadtmauer, EA Winter, J Van Vliet, A Berry, D Gray, R Jennis, A Goldberg, S Cooper, BW Preti, R
Citation: Al. Pecora et al., Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer, BONE MAR TR, 27(12), 2001, pp. 1245-1253

Authors: Nieto, Y Champlin, RE Wingard, JR Vredenburgh, JJ Elias, AD Richardson, PR Glaspy, J Jones, RB Stiff, PJ Bearman, SI Cagnoni, PJ McSweeney, PA LeMaistre, CF Pecora, AL Shpall, EJ
Citation: Y. Nieto et al., Status of high-dose chemotherapy for breast cancer: A review, BIOL BLOOD, 6(5), 2000, pp. 476-495

Authors: Goldberg, SL Pecora, AL Rosenbluth, RJ Jennis, AA Preti, RA
Citation: Sl. Goldberg et al., Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host effects with cytokines, BONE MAR TR, 26(3), 2000, pp. 353-355

Authors: Pecora, AL Stiff, P Jennis, A Goldberg, S Rosenbluth, R Price, P Goltry, KL Douville, J Armstrong, RD Smith, AK Preti, RA
Citation: Al. Pecora et al., Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulatedunrelated umbilical cord blood, BONE MAR TR, 25(7), 2000, pp. 797-799

Authors: Lazarus, HM Pecora, AL Shea, TC Koc, ON White, JM Gabriel, DA Cooper, BW Gerson, SL Krieger, M Sing, AP
Citation: Hm. Lazarus et al., CD34(+) selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome, BONE MAR TR, 25(5), 2000, pp. 559-566

Authors: Preti, RA Pecora, AL Ahmed, T Farley, TJ
Citation: Ra. Preti et al., CD34 selection using immunomagnetic beads, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 223-237

Authors: Pecora, AL
Citation: Al. Pecora, Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients, BONE MAR TR, 23, 1999, pp. S7-S12

Authors: Rowlings, PA Williams, SF Antman, KH Fields, KK Fay, JW Reed, E Pelz, CJ Klein, JP Sobocinski, KA Kennedy, MJ Freytes, CO McCarthy, PL Herzig, RH Stadtmauer, EA Lazarus, HM Pecora, AL Bitran, JD Wolff, SN Gale, RP Armitage, JO Vaughan, WP Spitzer, G Horowitz, MM
Citation: Pa. Rowlings et al., Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer, J AM MED A, 282(14), 1999, pp. 1335-1343

Authors: Shpall, EJ Wheeler, CA Turner, SA Yanovich, S Brown, RA Pecora, AL Shea, TC Mangan, KF Williams, SF LeMaistre, CF Long, GD Jones, R Davis, MW Murphy-Filkins, R Parker, WRL Glaspy, JA
Citation: Ej. Shpall et al., A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients, BLOOD, 93(8), 1999, pp. 2491-2501
Risultati: 1-13 |